141 related articles for article (PubMed ID: 16225480)
21. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
Ryan MC; Desmond PV; Slavin JL; Congiu M
J Viral Hepat; 2011 Jan; 18(1):53-60. PubMed ID: 20196803
[TBL] [Abstract][Full Text] [Related]
22. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
23. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
24. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
[TBL] [Abstract][Full Text] [Related]
25. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
26. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis.
Clouston AD; Powell EE; Walsh MJ; Richardson MM; Demetris AJ; Jonsson JR
Hepatology; 2005 Apr; 41(4):809-18. PubMed ID: 15793848
[TBL] [Abstract][Full Text] [Related]
27. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
Szanto P; Grigorescu M; Dumitru I; Serban A
J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005
[TBL] [Abstract][Full Text] [Related]
28. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
[TBL] [Abstract][Full Text] [Related]
29. Hepatic steatosis in Iranian patients with chronic hepatitis C.
Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
[TBL] [Abstract][Full Text] [Related]
30. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
31. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
Grassi A; Quarneti C; Ravaioli M; Bianchini F; Susca M; D'Errico A; Piscaglia F; Tamè MR; Andreone P; Grazi G; Galli S; Zauli D; Pinna AD; Bianchi FB; Ballardini G
Liver Transpl; 2006 Nov; 12(11):1673-81. PubMed ID: 17031825
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
33. Long-term reversal of hypocholesterolaemia in patients with chronic hepatitis C is related to sustained viral response and viral genotype.
Fernández-Rodríguez CM; López-Serrano P; Alonso S; Gutiérrez ML; Lledó JL; Pérez-Calle JL; Temiño R; Cacho G; Nevado M; Casas ML; Gasalla JM; Bonet B
Aliment Pharmacol Ther; 2006 Aug; 24(3):507-12. PubMed ID: 16886916
[TBL] [Abstract][Full Text] [Related]
34. Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis.
Franceschini B; Russo C; Dioguardi N; Grizzi F
J Viral Hepat; 2007 Aug; 14(8):549-55. PubMed ID: 17650288
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.
Negro F; Sanyal AJ
Liver Int; 2009 Mar; 29 Suppl 2():26-37. PubMed ID: 19187070
[TBL] [Abstract][Full Text] [Related]
37. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
Serfaty L; Capeau J
Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
[TBL] [Abstract][Full Text] [Related]
39. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C and steatosis: a reappraisal.
Lonardo A; Loria P; Adinolfi LE; Carulli N; Ruggiero G
J Viral Hepat; 2006 Feb; 13(2):73-80. PubMed ID: 16436124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]